$SAVA “Michael, as mild-moderate AD patient what do you think is easier?”

A) Going to the hospital every two weeks to get an infusion with risk of brain swelling?(Leqembi,etc.)
B) A safe & cognition enhancing pill twice a day?(Simufilam)

Rethink ph3 trial readout in Q4! #ENDALZ

$SAVA 'Pill Form' is the holy grail of Biotechnology development #simufilam #ENDALZ

I just heard from Dr Doug that the two moderate patients in the $Sava taking simufilam “continue to be stable 3 plus years out from initially entering the phase 2 study.”

So his initial reports were that these patients experienced dramatic reversals of their #Alzheimers …

$SAVA #ENDALZ $PLS Freedom of speech!
I created the 1st ever decentralized paper on Alzheimer's research stored on the Pulsechain
Altered filamin A enables amyloid beta-induced tau hyperphosphorylation and neuroinflammation in Alzheimer’s disease Burns, Wang #simufilam

$SAVA Simufilam Filamin A Alzheimer’s research by Burns, Wang 2017 is now forever imprinted on the blockchain. Open the fully decentralised paper here …ld-shared-kangaroo-378.mypinata.cloud/ipfs/QmTNLQQgR…

Vinnie Matt Nachtrab Joe Springer Cassava Sciences - Unofficial There is no doubt with every test, it shows that #Simufilam has an effect on #Alzheimers . $SAVA Cassava Sciences - Unofficial

Great interview of Matt Nachtrab by Joe Springer.
2 important points: Matt visited Dr. Wang in lab & 'saw the freezers' which gave him more confidence in $SAVA.
Phase2 didn't have good diagnostics for #Alzheimers yet, but screening for Phase3 much improved. Cassava Sciences - Unofficial

$SAVA Undeniable facts!
✅Simufilam showed improving cognition in mild AD patients throughout Ph2 trials
✅No adverse events after >1M doses given
✅Ph3 trials endorsed by SPA agreement with the FDA
✅Last patient dosing in ‘Rethink’ Ph3 trial is less than 6 months away
#ENDALZ

Oh the Irony: An approved #simufilam may one day successfully treat those who develop #Alzheimer 's, that stems from stress, caused by betting against $SAVA and attempting to thwart Cassava Sciences - Unofficial success.

isglobal.org/en/-/vivencias…

Alzheimer's Association The best way to improve the lives for those suffering with AD is to find safer more effective treatments. Cassava Sciences has two P3 trials underway for simufilam and will have efficacy results later in 2024. Simufilam could be a game changer for those suffering with AD. #ENDALZ

What is one more quality day with a love one worth? How to value living independently as an adult? How do you value minimizing the burden on a family caregiver. What is the value of a product that offers an affirmative to these questions globally. Simufilam -- worth knowing

Here's #Simufilam vs Leqembi.
$SAVA Cassava Sciences - Unofficial

ChrisRock002 The fact that simufilam is a pill treatment rather than an intravenous one is definitely a huge advantage. It will be much easier for AD patients to take a pill, and it should cost less than intravenous treatments. Looking forward to the P3 trial results! #CassavaSciences #ENDALZ

Matt Nachtrab Going 2B perfect storm. Short Squeeze-mageddon

Lilly Medical US I am most excited about Cassava Sciences and their drug simufilam in Phase 3 trials for treating Alzheimer’s. #CassavaSciences #ENDALZ

Matt Nachtrab This is incredible news! I wish organizations like the Alzheimer's Association would focus on helping those suffering from AD by finding safe and effective treatments instead of just coping with AD. There is real hope for those suffering with AD with $SAVA's simufilam. #ENDALZ

Alzheimer's Association Would you mention Simufilam, Cassava Sciences promising Alzheimers drug while you're there?

Alzheimer's Association Maria Carrillo No discussion about hope for those with AD would be complete without talking about $SAVA and its two P3 trials for simufilam currently underway. Research to date has shown that simufilam is a safe, effective, and disease modifying treatment. P3 efficacy results coming in 2024!